Google fund invests in CRISPR start-up

14-05-2019

Google fund invests in CRISPR start-up

mariax / Shutterstock.com

Alphabet-owned GV (formerly Google Ventures) has invested in Verve Therapeutics, a cardiovascular company developing gene editing therapies aiming to permanently reduce the risk of coronary artery disease.


Google, Alphabet, Google Ventures, Verve Therapeutics, coronary artery disease, CRISPR, gene editing, genetics, cardiovascular

LSIPR